Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
37
|
pubmed:dateCreated |
1996-11-7
|
pubmed:abstractText |
Inverse agonists are ligands that are capable of repressing basal receptor activity in the absence of an agonist. We have designed a series of C-1-substituted acetylenic retinoids that exhibit potent antagonism of retinoic acid receptor (RAR)-mediated transactivation. Comparison of these related retinoid antagonists for their ability to repress basal RAR transcriptional activity demonstrates that the identity of the C-1 substituent differentiates these ligands into two groups: RAR inverse agonists and neutral antagonists. We show that treatment of cultured human keratinocytes with a RAR inverse agonist, but not a RAR neutral antagonist, leads to the repression of the serum-induced differentiation marker MRP-8. While RAR-selective agonists also repress expression of MRP-8, cotreatment with a RAR inverse agonist and a RAR agonist results in a mutual repression of their individual inhibitory activities, indicating the distinct modes of action of these two disparate retinoids in modulating MRP-8 expression. Our data indicate that RARs, like beta2-adrenoreceptors, are sensitive to inverse agonists and that this new class of retinoids will provide insight into the molecular mechanisms of RAR function in skin and other responsive tissues.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AGN 193109,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Calgranulin A,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoids
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
22692-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8798442-Antigens, Differentiation,
pubmed-meshheading:8798442-Binding, Competitive,
pubmed-meshheading:8798442-Calcium-Binding Proteins,
pubmed-meshheading:8798442-Calgranulin A,
pubmed-meshheading:8798442-Cells, Cultured,
pubmed-meshheading:8798442-Humans,
pubmed-meshheading:8798442-Keratinocytes,
pubmed-meshheading:8798442-Naphthalenes,
pubmed-meshheading:8798442-Receptors, Adrenergic, beta,
pubmed-meshheading:8798442-Receptors, Retinoic Acid,
pubmed-meshheading:8798442-Retinoids,
pubmed-meshheading:8798442-Transcription, Genetic
|
pubmed:year |
1996
|
pubmed:articleTitle |
Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists.
|
pubmed:affiliation |
Department of Biology, Retinoid Research, Allergan Pharmaceuticals, Irvine, California 92715, USA.
|
pubmed:publicationType |
Journal Article
|